NO20023448L - Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin - Google Patents

Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin

Info

Publication number
NO20023448L
NO20023448L NO20023448A NO20023448A NO20023448L NO 20023448 L NO20023448 L NO 20023448L NO 20023448 A NO20023448 A NO 20023448A NO 20023448 A NO20023448 A NO 20023448A NO 20023448 L NO20023448 L NO 20023448L
Authority
NO
Norway
Prior art keywords
depression
treatment
related disorders
drug combination
disorders including
Prior art date
Application number
NO20023448A
Other languages
English (en)
Other versions
NO20023448D0 (no
Inventor
John Stuart Andrews
Wilhelmus Drinkenburg
Nicholas Matthew Ward
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20023448D0 publication Critical patent/NO20023448D0/no
Publication of NO20023448L publication Critical patent/NO20023448L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20023448A 2000-01-19 2002-07-18 Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin NO20023448L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00200189 2000-01-19
PCT/EP2001/000407 WO2001052855A2 (en) 2000-01-19 2001-01-15 Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone

Publications (2)

Publication Number Publication Date
NO20023448D0 NO20023448D0 (no) 2002-07-18
NO20023448L true NO20023448L (no) 2002-09-17

Family

ID=8170928

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20023448A NO20023448L (no) 2000-01-19 2002-07-18 Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin

Country Status (21)

Country Link
US (2) US6835728B2 (no)
EP (1) EP1251854A2 (no)
JP (1) JP2003520237A (no)
KR (1) KR20020068404A (no)
CN (1) CN1223349C (no)
AR (1) AR027240A1 (no)
AU (1) AU780817B2 (no)
BR (1) BR0107721A (no)
CA (1) CA2396066A1 (no)
CO (1) CO5261583A1 (no)
HK (1) HK1047548A1 (no)
HU (1) HUP0204050A3 (no)
IL (1) IL150289A0 (no)
MX (1) MXPA02007095A (no)
NO (1) NO20023448L (no)
PE (1) PE20011049A1 (no)
PL (1) PL356605A1 (no)
RU (1) RU2268725C2 (no)
SK (1) SK10552002A3 (no)
WO (1) WO2001052855A2 (no)
ZA (1) ZA200205161B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
US20060039866A1 (en) * 2004-08-20 2006-02-23 Cypress Bioscience, Inc. Method for treating sleep-related breathing disorders
EP1827450A4 (en) * 2004-11-17 2009-04-22 Cypress Bioscience Inc METHOD FOR REDUCING THE SIDE EFFECTS OF TREATMENT WITH MIRTAZAPINE
GT200600416A (es) 2005-09-12 2007-09-20 Sales salicilato y gentisato de un compuesto de piperazina
AR055424A1 (es) 2005-09-12 2007-08-22 Wyeth Corp Formulacion de liberacion sostenida y usos de la misma
GT200600414A (es) 2005-09-12 2007-09-20 Sal de glucuranato de compuesto de piperazine
EP1792618A1 (en) * 2005-11-30 2007-06-06 Rainer Freynhagen R-mirtazapine for the treatment of pain
AU2007253704A1 (en) * 2006-05-22 2007-11-29 Vanda Pharmaceuticals, Inc. Treatment for depressive disorders
TW200808804A (en) * 2006-05-22 2008-02-16 Organon Nv Mirtazapine for the treatment of neuropathic pain
EP2167096A4 (en) * 2007-06-13 2010-07-14 Cypress Bioscience Inc IMPROVING TOLERANCE TO MIRTAZAPINE AND A SECOND ACTIVE INGREDIENT BY THE COMBINED USE OF THEM
MX2010004788A (es) * 2007-11-02 2010-09-14 Acrux Dds Pty Ltd Sistema de liberacion transdermica.
EP2576520A1 (en) 2010-05-28 2013-04-10 GE Healthcare UK Limited Radiolabeled compounds and methods thereof
GB201112987D0 (en) 2011-07-28 2011-09-14 Ge Healthcare Ltd Novel compound
CN108743593B (zh) * 2018-08-31 2019-03-26 程世宏 一种抗抑郁药物及其口服颗粒剂和制药用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4423049A (en) * 1981-12-28 1983-12-27 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines
US4771053A (en) * 1987-03-02 1988-09-13 Bristol-Myers Company Method for alleviation of primary depressive disorders
US5114976A (en) * 1989-01-06 1992-05-19 Norden Michael J Method for treating certain psychiatric disorders and certain psychiatric symptoms
US5011841B1 (en) * 1989-11-14 1994-09-06 Pfizer Treatment of depression
IE63986B1 (en) * 1989-12-30 1995-06-28 Akzo Nv Pharmaceutical preparation for oral administration in fluid form
HU215410B (hu) * 1992-10-07 1998-12-28 Akzo N.V. Eljárás enantiomerek elkülönítésére racém elegyből
FR2701260B1 (fr) * 1993-02-05 1995-05-05 Esteve Labor Dr Dérivés de 2-[4-(4-azolylbutyl)-1-pipérazinyl]-5-hydroxypyrimidine, leur préparation et leur application en tant que médicaments.
GB9303968D0 (en) 1993-02-26 1993-04-14 Wyeth John & Brother Ltd 5-ht1a ligands
IL114026A (en) * 1994-06-08 1999-06-20 Lundbeck & Co As H 4-aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzo thiophenemethyl) piperidines tetrahydropyridines or piperazines and pharmaceutical compositions containing them
GB9603136D0 (en) * 1996-02-15 1996-04-17 Merck Sharp & Dohme Therapeutic agents
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
TW587938B (en) 1997-03-27 2004-05-21 Akzo Nobel Nv Pharmaceutical composition for the treatment and/or prophylaxis of psychotic disorder
ZA982368B (en) * 1997-03-27 1998-09-23 Akzo Nobel Nv New therapeutic combinations

Also Published As

Publication number Publication date
WO2001052855A2 (en) 2001-07-26
BR0107721A (pt) 2002-10-01
PL356605A1 (en) 2004-06-28
IL150289A0 (en) 2002-12-01
US20030105083A1 (en) 2003-06-05
WO2001052855A8 (en) 2002-12-27
CN1395486A (zh) 2003-02-05
NO20023448D0 (no) 2002-07-18
RU2002122084A (ru) 2004-03-10
AU780817B2 (en) 2005-04-21
AR027240A1 (es) 2003-03-19
PE20011049A1 (es) 2001-10-18
US6835728B2 (en) 2004-12-28
RU2268725C2 (ru) 2006-01-27
HUP0204050A2 (hu) 2003-03-28
MXPA02007095A (es) 2003-04-14
HUP0204050A3 (en) 2004-09-28
CN1223349C (zh) 2005-10-19
HK1047548A1 (zh) 2003-02-28
WO2001052855A3 (en) 2002-01-10
JP2003520237A (ja) 2003-07-02
SK10552002A3 (sk) 2002-12-03
KR20020068404A (ko) 2002-08-27
AU2516201A (en) 2001-07-31
ZA200205161B (en) 2003-09-29
CA2396066A1 (en) 2001-07-26
EP1251854A2 (en) 2002-10-30
US20050090488A1 (en) 2005-04-28
CO5261583A1 (es) 2003-03-31

Similar Documents

Publication Publication Date Title
ATE318590T1 (de) Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen
DE60142473D1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
NO20021845L (no) Behandling av sovnforstyrrelser under anvendelse av desloratadin
ATE286028T1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
NO20022680L (no) Farmasoytiske kombinasjoner og deres anvendelse ved behandling av gastrointestinale forstyrrelser
EE200200442A (et) Piperasiini ja piperidiini derivaadid neuronaalsete kahjustuste raviks
NO20043085L (no) Fremgangsmater og sammensetninger for behandling av forstyrrelser i sentralnervesystemet
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20023448D0 (no) Medikamentkombinasjon for behandling av depresjon og beslektede forstyrrelser omfattende mirtazapin
NO20032636D0 (no) 3-indolinderivater som er nyttige i behandlingen av psykiatriske og nevrologiske forstyrrelser
NO20023482D0 (no) Fremgangsmåte for behandling av stoffmisbruk
NO20024486L (no) Forbedret behandling av neovaskularisering
NO20033123D0 (no) Terapeutisk hinnedannende sammensetning og behandlingsplan derav
IS6137A (is) Meðhöndlun á hugsýkistruflunum
IL158704A0 (en) 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
ZA200309513B (en) Novel heterocyclic derivatives and medicinal use thereof.
NO20024777L (no) Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
IL158703A0 (en) 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
NO20023803L (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
NO20032156D0 (no) Behandling av angstforstyrrelser
IL158632A0 (en) 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
NO20032006L (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application